Continental Chemicals has provided an update on the utilization of funds from a past preferential issue.

The company raised 1.625 Cr specifically for working capital.

This report confirms that there has been no deviation or variation in how these funds were used, and they were fully deployed for the intended purpose.

This transparency assures investors that the capital raised has been managed effectively and in line with stated objectives, reflecting sound financial stewardship.

The audit committee has also reviewed and approved this status.